テネシーにおけるCOPDの臨床試験
テネシー内の拠点で、COPDに関する14件の研究が参加者を募集しています。
テネシー内の都市
公式研究テキスト（英語）
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Chattanooga Research and Medicine- Site Number : 8400026, Chattanooga
- Premier Research Center, Llc- Site Number : 8400146, Hendersonville
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/10/01更新 · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Meharry Medical College- Site Number : 8400133, Nashville
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07190209An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Fort Sanders Regional Medical Center (StatCare), Knoxville
被験者募集中
40歳〜80歳 · 全性別 · 2026/09/17更新 · NCT06035120A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Chattanooga
- Research Site, Franklin
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/09更新 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Vanderbilt University Medical Center, Nashville
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/04更新 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Knoxville
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Franklin
- Research Site, Johnson City
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Clinical Trials Center of Middle Tennessee, LLC, Franklin
- Premier Research Center, LLC, Hendersonville
被験者募集中第2/3相
35歳〜80歳 · 全性別 · 2026/08/31更新 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Chattanooga
- Research Site, Franklin
- Research Site, Tullahoma
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/08/26更新 · NCT06283966Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
- The University of Tennessee Graduate School of Medicine, Knoxville
被験者募集中第4相
40歳以上 · 全性別 · 2026/08/17更新 · NCT07133880eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Knoxville
被験者募集中第3相
40歳〜75歳 · 全性別 · 2026/07/28更新 · NCT07177339Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Methodist LeBonheur Healthcare, Memphis
被験者募集中観察研究
18歳以上 · 全性別 · 2026/07/10更新 · NCT05181826Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Knoxville
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/04/09更新 · NCT06961214Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- The Jackson Clinic, PA, Jackson
被験者募集中観察研究
50歳以上 · 全性別 · 2025/08/05更新 · NCT06122077ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。